Nuveen
ONCR

Nuveen’s Oncorus, Inc. ONCR Stock Holding History

Nuveen’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-96,208
Closed -$159K – 3577
2022
Q1 		$159K Buy
96,208
+2,957
+3% +$8.28K ﹤0.01% 3218
2021
Q4 		$455K Sell
93,251
-25,045
-21% -$194K ﹤0.01% 3092
2021
Q3 		$1.14M Buy
118,296
+863
+0.7% +$9.85K ﹤0.01% 2944
2021
Q2 		$1.62M Buy
117,433
+95,508
+436% +$1.48M ﹤0.01% 2805
2021
Q1 		$305K Buy
21,925
+11,062
+102% +$229K ﹤0.01% 3170
2020
Q4 		$351K Buy
+10,863
New +$252K ﹤0.01% 3112

Other funds holding ONCR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen's ONCR Position: Q2 2022 in Review

Nuveen sold out of Oncorus, Inc. (ONCR) in Q2 2022, closing a stake of 96,208 shares — an estimated $159K sold.

Nuveen first reported a position in ONCR in Q4 2020 and held it in 6 quarters. The position peaked at $1.62M in Q2 2021. 45 funds tracked by Wall St. Rank hold ONCR as of Q2 2022.

  • Nuveen reported no remaining Oncorus, Inc. position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 96,208 Oncorus, Inc. shares in Q2 2022, an estimated $159K.
  • Nuveen first reported a position in Oncorus, Inc. in Q4 2020 and held it in 6 quarters.
  • Nuveen's Oncorus, Inc. position peaked at $1.62M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.